NCT06027541View on ClinicalTrials.gov

Young Patients With Early Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

February 1, 2028

Conditions
Breast Cancer Female
Interventions
PROCEDURE

operation

operation methods: breast-conserving surgery, mastectomy, axillary lymph node dissection, sentinal lymphnodes biopsy; chemotherapy regimens: AC, TC, AC-T/P, TCrb, TAC, capecitabine; ovarian protection:GnRHa; endocrine therapy: Aromatase inhibitor, GnRHa, TAM, Fulvestrant, CDK4/6 inhibitors; target therapy: trastuzumab，patuzumab, Pyrotinib.

Trial Locations (1)

Unknown

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER